EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset
Modern Pathology2009Vol. 22(4), pp. 508–515
Citations Over TimeTop 1% of 2009 papers
Kentaro Inamura, Kengo Takeuchi, Yuki Togashi, Satoko Hatano, Hironori Ninomiya, Noriko Motoi, Mingyon Mun, Yukinori Sakao, Sakae Okumura, Ken Nakagawa, Manabu Soda, Young Lim Choi, Hiroyuki Mano, Yuichi Ishikawa
Related Papers
- → ALK G1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor(2017)39 cited
- → Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma(2012)31 cited
- → Success of Crizotinib Combined with Whole-Brain Radiotherapy for Brain Metastases in a Patient with Anaplastic Lymphoma Kinase Rearrangement-Positive Non-Small-Cell Lung Cancer(2018)12 cited
- → Second-generation anaplastic lymphoma kinase inhibitors: revolutionary or evolutionary?(2016)1 cited